drugset / Trial / NCT00567177

Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease

NCT00567177

Phase 4 Completed 40 enrolled Innovative Medical
RandomizedParallel-groupDouble-blindTreatment

Summary

We propose to investigate the response to Restasis, over a prolonged period of time in heavy computer users with dry eye disease.

Timeline

Start
2007-11
Primary completion
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyclosporine Peptide 0.4 ml Other

Indications